Combination use of triamcinolone acetonide and immunotherapy as a new therapeutic option in alopecia totalis
作者: Takashi Yoshimasu, Naoya Mikita, Takaharu Ikeda, Nobuo Kanazawa, Fukumi Furukawa, Masatoshi Jinnin
刊名: Trends in Immunotherapy, 2018, Vol.2 (1)
来源数据库: EnPress Publisher
DOI: 10.24294/ti.v2.i1.149
关键词: Alopecia totalisTriamcinolone acetonideSADBEDPCPImmunotherapy
原始语种摘要: Alopecia totalis (AT) with body hair loss is the most severe type of alopecia areata (AA). The ability to develop hair is suggested to be poor in such severe AA, because AT does not respond to corticosteroid pulses and immunotherapy using squaric acid dibutylester (SADBE) or diphenylcyclopropenone (DPCP). The purpose of this study is to assess the possibility of hair regrowth in AT with body hair loss. Ten patients with AT who did not respond to topical immunotherapies, received triamcinolone acetonide (TA) injections. Undiluted or 2-fold diluted solutions of TA were prepared and 0.10.2 mL of either of the two solutions was administered to each patient. In total, 2 mL of the selected solution was injected monthly into each area. In cases where vellus hair developed after the injections,...
全文获取路径: PDF下载  EnPress Publisher  (合作)
分享到:

×
关键词翻译
关键词翻译
  • alopecia 脱发
  • immunotherapy 免疫疗法
  • triamcinolone 氟羟脱氢皮甾醇
  • therapeutic 治疗的
  • injections 用政府支出来刺激需求增长
  • corticosteroid 皮质甾类
  • respond 应答
  • susceptibility 磁化率
  • developed 开发
  • vellus 胎毛